Cargando…

Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage

BACKGROUND: The impact of different disease stages and treatment for human epidermal growth factor 2 positive (HER2-positive) breast cancer (BC) on work productivity and health-related quality of life (HRQoL) is poorly understood. METHODS: This was a UK cross-sectional study of 299 adult patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verrill, Mark, Wardley, Andrew M., Retzler, Jenny, Smith, Adam B., Bottomley, Catherine, Ní Dhochartaigh, Sorcha, Tran, Irwin, Leslie, Iain, Schmid, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607622/ https://www.ncbi.nlm.nih.gov/pubmed/33138835 http://dx.doi.org/10.1186/s12955-020-01603-w

Ejemplares similares

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
por: Sutherland, S, et al.
Publicado: (2010)

Arrangement of Kv1 α subunits dictates sensitivity to tetraethylammonium
por: Al-Sabi, Ahmed, et al.
Publicado: (2010)

Person-centred Approaches to Psychopathology in the ABCD Study: Phenotypes and Neurocognitive Correlates
por: Retzler, Chris, et al.
Publicado: (2023)

Using Drift Diffusion Modeling to Understand Inattentive Behavior in Preterm and Term-Born Children
por: Retzler, Jenny, et al.
Publicado: (2019)

Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature
por: Thanopoulou, Eirini, et al.
Publicado: (2020)

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer
por: Hong, Joohyun, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer
por: Tran, Phuong T., et al.
Publicado: (2020)

Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer
por: Miles, Jennifer, et al.
Publicado: (2018)

Chemotherapy for early-stage breast cancer: a brief history
por: Verrill, M
Publicado: (2009)

Item banking and computer-adaptive testing in clinical trials: Standing in sight of the PROMISed land
por: Smith, Adam B., et al.
Publicado: (2018)

Pathology and regulation for research in the UK: an overview
por: Driskell, Owen John, et al.
Publicado: (2019)

Prior information use and response caution in perceptual decision-making: No evidence for a relationship with autistic-like traits
por: Retzler, Chris, et al.
Publicado: (2021)

Standard Gamble to Derive Utility Health States for Limbal Stem Cell Deficiency
por: Smith, Adam B, et al.
Publicado: (2020)

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage
por: Howell, S J, et al.
Publicado: (2009)

Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results
por: Hiller, Louise, et al.
Publicado: (2018)

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)

The Dual Blockade in the Neoadjuvant Setting of HER-2 Positive Early-Stage Breast Cancer
por: Pop, Lucian, et al.
Publicado: (2019)

HER-2 positivity is a high risk of recurrence of stage I gastric cancer
por: Kim, Seonhoo, et al.
Publicado: (2021)

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Inicie su negocio de servicio y hágalo prosperar
por: Retzler, Kathryn
Publicado: (1990)

Atwood on her work : "Poems open the doors. Novels are the corridors" /
por: Atwood, Margaret, 1939-
Publicado: (2006)

Are the opportunities to prevent alcohol related liver deaths in the UK in primary or secondary care? A retrospective clinical review and prospective interview study
por: Verrill, Clare, et al.
Publicado: (2006)

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
por: Lin, Nancy U., et al.
Publicado: (2020)

Positive working relationships
por: Pergamon Flexible Learning
Publicado: (2008)

Process utilities for topical treatment in atopic dermatitis
por: Retzler, Jenny, et al.
Publicado: (2019)

The impact of increased post-progression survival on the cost-effectiveness of interventions in oncology
por: Retzler, Jenny, et al.
Publicado: (2019)

Updated UK Recommendations for HER2 assessment in breast cancer
por: Rakha, Emad A, et al.
Publicado: (2015)

Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer
por: Kim, Yong-Seok, et al.
Publicado: (2022)

Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2023)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
por: Ishimine, Yu, et al.
Publicado: (2015)

The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
por: Wardley, Andrew, et al.
Publicado: (2021)

Staging work-up of patients with esophageal cancer
por: Quint, Leslie E.
Publicado: (2007)

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
por: Prat, Aleix, et al.
Publicado: (2022)

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
por: Novillo, Apolonia, et al.
Publicado: (2023)

The Shropshire Lass and Her Goitre: Some Account of Mary Meredith Webb and Her Works
por: Pitfield, Robert Lucas
Publicado: (1942)

Work-Family Conflict and Work Exit in Later Career Stage
por: Xue, Baowen, et al.
Publicado: (2020)

Systematic Review of Studies Reporting Positive Surgical Margins After Bladder Neck Sparing Radical Prostatectomy
por: Bellangino, Mariangela, et al.
Publicado: (2017)

Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer
por: DOWN, SUE K., et al.
Publicado: (2014)

Matters Arising: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Alaa, Ahmed M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jar2d182e6g6h0b5fabmamet6f